CD8A and neoplasm: Furthermore, the combination of SDT and anti‐CD47 immunotherapy could synergistically suppress tumor proliferation by increasing intratumoral infiltration of CD3+CD8+ T cells and reducing the frequency of immunosuppressive Tregs.[97] These might all be attributed to ICD‐induced antitumor responses.